Fructans: Clinical Trials

6 trials of Fructans, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 recruiting. 5 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 5
Phase 21Recruiting 1

Follow Fructans: new trials by email Literature Review of Fructans trials Research Report on Fructans

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psyllium in Pediatric IBS
Psyllium (0.7 g/year of age per day), Psyllium (0.5 g/year of age per day), Placebo - Irritable Bowel Syndrome
Phase 2RecruitingDr Bruno Chumpitazi, M.D.1102025-02-202026-05-26
Brain and Gut Responses to Intragastric Administration of FODMAPs in Healthy Subjects and Patients With Irritable Bowel Syndrome
Fructans, Glucose, Saline - Irritable Bowel Syndrome
Not applicableCompletedUniversitaire Ziekenhuizen KU Leuven282018-02-222021-05-28
Assessment of the Effects of Synbiotic on Gut Microbiota Composition in Scholars With Overweight
Lactobacillus casei strain Shirota, Lactobacillus casei strain Shirota plus inulin, Lactobacillus casei strain Shirota plus fructans from A. salmiana - Childhood Obesity, Childhood Overweight
Not applicableCompletedUniversidad Autonoma de San Luis Potosí372017-07-212022-06-21
Microbiome Fructan Metabolism and Symptoms in Childhood IBS
Fructan, Maltodextrin - Irritable Bowel Syndrome (IBS)
Not applicableCompletedBaylor College of Medicine552014-09-012021-01-22
Fructose and Fructans in Irritabla Bowel Syndrome
Glucose, Fructose, Fructans - Irritable Bowel Syndrome
Not applicableCompletedUniversity of Nottingham692013-01-012016-05-13
Effects of FODMAPs on Small Bowel Water Content: an MRI Study
Glucose, Fructose, Fructan - Healthy
Not applicableCompletedUniversity of Nottingham172011-10-012012-12-19

Conditions studied

Irritable Bowel Syndrome (4)  ·  Abdominal Pain (2)  ·  Diarrhea (1)  ·  Flatulence (1)  ·  Pediatric Obesity (1)

Sponsors

University of Nottingham (2)  ·  Baylor College of Medicine (1)  ·  Dr Bruno Chumpitazi, M.D. (1)  ·  Universidad Autonoma de San Luis Potosí (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)

Countries

United Kingdom (2)  ·  United States (2)  ·  Belgium (1)  ·  Mexico (1)

Top investigators

Bruno Chumpitazi, MD, MPH (2)  ·  Giles AD Major, BM BCh MA MRCP (1)  ·  Jan Tack, MD, PHD (1)  ·  Robin C Spiller, MB BChir MSc MD FRCP (1)  ·  Robin C Spiller, MD FRCP (1)

Results publications

PMID 27746233, PMID 28970147, PMID 35166384, PMID 36856122

NIH funding

K23DK101688 (1)